25-1036 • December 10, 2021
Class Period Start
November 25, 2019
Class Period End
October 15, 2021
PSLRA Deadline
February 8, 2022
Case Allegations
10b5
Statutes of Repose
Nov 25, 2022
Country
United States
Court
Federal Court
Feb 19, 2025
Jan 17, 2025
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
May 28, 2024
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 1, 2024
A new complaint has been filed on behalf of certain investors in Revance Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Apr 2, 2024
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Jan 23, 2023
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Nov 7, 2022
A new complaint has been filed on behalf of certain investors in Revance Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Sep 7, 2022
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Dec 10, 2021
A securities fraud class action complaint has been filed on behalf of certain investors in Revance Therapeutics, Inc..
TOP
